Fexeric (ferric citrate coordination complex)
Additional monitoring
- Region
- 🇪🇺 EU
- Active substance
- ferric citrate coordination complex
- Company
- Akebia Europe Limited
- Status
- Lapsed
- Therapeutic area
- Hyperphosphatemia; Renal Dialysis
- EU approval
- Wed 23 Sep 2015
- Designations
- Additional monitoring
- Application
- EMEA/H/C/003776
- ATC
- V03AE
- Official record
- www.ema.europa.eu
Indication
Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Xoanacyl Authorised · Averoa
Follow Fexeric
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.